CN116058388A - Composition capable of sterilizing and inhibiting viruses and application thereof - Google Patents
Composition capable of sterilizing and inhibiting viruses and application thereof Download PDFInfo
- Publication number
- CN116058388A CN116058388A CN202310050130.5A CN202310050130A CN116058388A CN 116058388 A CN116058388 A CN 116058388A CN 202310050130 A CN202310050130 A CN 202310050130A CN 116058388 A CN116058388 A CN 116058388A
- Authority
- CN
- China
- Prior art keywords
- essential oil
- composition
- copper powder
- mask
- viruses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 61
- 239000000203 mixture Substances 0.000 title claims abstract description 55
- 230000001954 sterilising effect Effects 0.000 title claims abstract description 32
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 17
- 239000000341 volatile oil Substances 0.000 claims abstract description 88
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 33
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 33
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 27
- 241000208152 Geranium Species 0.000 claims abstract description 13
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 12
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 12
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 12
- 244000166124 Eucalyptus globulus Species 0.000 claims abstract description 12
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 12
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 12
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 12
- 240000002505 Pogostemon cablin Species 0.000 claims abstract description 12
- 235000011751 Pogostemon cablin Nutrition 0.000 claims abstract description 12
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 12
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 12
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 11
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 11
- 235000011187 glycerol Nutrition 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims description 21
- 230000000844 anti-bacterial effect Effects 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 230000003253 viricidal effect Effects 0.000 claims 2
- 239000011259 mixed solution Substances 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 21
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 15
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 abstract description 9
- 229910001431 copper ion Inorganic materials 0.000 abstract description 9
- 241000196324 Embryophyta Species 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 6
- 238000000605 extraction Methods 0.000 abstract description 6
- 230000000694 effects Effects 0.000 description 12
- 239000010410 layer Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 239000004745 nonwoven fabric Substances 0.000 description 10
- 230000006870 function Effects 0.000 description 7
- 239000004753 textile Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000000835 fiber Substances 0.000 description 5
- 238000003556 assay Methods 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 241001678559 COVID-19 virus Species 0.000 description 3
- 241000711573 Coronaviridae Species 0.000 description 3
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 210000004779 membrane envelope Anatomy 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- DZNVIZQPWLDQHI-UHFFFAOYSA-N Citronellyl formate Chemical compound O=COCCC(C)CCC=C(C)C DZNVIZQPWLDQHI-UHFFFAOYSA-N 0.000 description 2
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 2
- 239000005751 Copper oxide Substances 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910000431 copper oxide Inorganic materials 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241001440741 CHER virus Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 244000309467 Human Coronavirus Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 241001263478 Norovirus Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- ZHYZQXUYZJNEHD-VQHVLOKHSA-N geranic acid Chemical compound CC(C)=CCC\C(C)=C\C(O)=O ZHYZQXUYZJNEHD-VQHVLOKHSA-N 0.000 description 1
- 229930008392 geranic acid Natural products 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 229940105040 geranium extract Drugs 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002074 melt spinning Methods 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 210000003695 paranasal sinus Anatomy 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical compound [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 229930006978 terpinene Natural products 0.000 description 1
- 150000003507 terpinene derivatives Chemical class 0.000 description 1
- 229940116411 terpineol Drugs 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- ZHYZQXUYZJNEHD-UHFFFAOYSA-N trans-geranic acid Natural products CC(C)=CCCC(C)=CC(O)=O ZHYZQXUYZJNEHD-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
- A01N59/20—Copper
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/22—Lamiaceae or Labiatae [Mint family], e.g. thyme, rosemary, skullcap, selfheal, lavender, perilla, pennyroyal, peppermint or spearmint
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/24—Lauraceae [Laurel family], e.g. laurel, avocado, sassafras, cinnamon or camphor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/28—Myrtaceae [Myrtle family], e.g. teatree or clove
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/36—Rutaceae [Rue family], e.g. lime, orange, lemon, corktree or pricklyash
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D13/00—Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
- A41D13/05—Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches protecting only a particular body part
- A41D13/11—Protective face masks, e.g. for surgical use, or for use in foul atmospheres
- A41D13/1192—Protective face masks, e.g. for surgical use, or for use in foul atmospheres with antimicrobial agent
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D31/00—Materials specially adapted for outerwear
- A41D31/04—Materials specially adapted for outerwear characterised by special function or use
- A41D31/30—Antimicrobial, e.g. antibacterial
- A41D31/305—Antimicrobial, e.g. antibacterial using layered materials
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
- D06M11/83—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with metals; with metal-generating compounds, e.g. metal carbonyls; Reduction of metal compounds on textiles
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/005—Compositions containing perfumes; Compositions containing deodorants
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/10—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing oxygen
- D06M13/144—Alcohols; Metal alcoholates
- D06M13/148—Polyalcohols, e.g. glycerol or glucose
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M16/00—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The invention discloses a composition capable of sterilizing and inhibiting viruses and application thereof, and relates to the technical field of sterilizing preparations, wherein the technical key points are as follows: the composition comprises the following components in percentage by mass: 0.4-0.6% of patchouli essential oil, 0.2-0.3% of lemon essential oil, 0.1-0.2% of geranium essential oil, 0.5-1% of cinnamon essential oil, 0.5-1% of eucalyptus essential oil, 0.2-0.3% of clove essential oil, 0.3-0.5% of peppermint essential oil, 45-55% of water, 8-12% of glycerin, 30-35% of propylene glycol and 3-7% of nano copper powder. The invention adopts the composition of natural plant extraction medicament and nano copper powder for double sterilization, which can instantly kill more than 99 percent of bacteria and viruses, the nano copper powder can kill the residual bacteria and viruses for a long time, and the superfine copper powder copper ions can be naturally metabolized by human body and can not be accumulated in the human body; the composition can be applied to mask sterilization, and the effective shelf life and sterilization time of the mask can reach 2 years.
Description
Technical Field
The invention relates to the technical field of sterilization preparations, in particular to a composition capable of sterilizing and inhibiting viruses and application thereof.
Background
The characteristics of viruses are between living and non-living, neither living nor non-living, are in a particulate state, are about one percent of bacteria in size, are above 50 nanometers, and are parasitic to host cell systems for self replication by the mechanism of infection, but cannot grow and replicate independently. In the market, a plurality of multifunctional sterilization modes, such as nano silver, fiber copper, copper oxide, solid alkali and the like, are also newly introduced, but the nano silver, fiber copper, copper oxide, solid alkali filter materials are all single material sterilization and are all physical filtration.
At present, the general mask in the market is generally purely resistant to bacteria and viruses, and cannot effectively play a role when the mask is continuously used for more than 3-4 hours, meanwhile, the current mask cannot kill bacteria and viruses, a certain potential risk exists, and further, people can breathe uncomfortable after wearing the mask for a long time, so that mental state is bad.
In view of this, the present patent is filed.
Disclosure of Invention
The invention aims to solve the problems and provide a composition capable of sterilizing and inhibiting viruses and application thereof, wherein the natural plant extraction reagent and nano copper powder double sterilization mode is adopted to kill viruses and eliminate bacteria, so that the bacteria and viruses can be killed for a long time.
In order to achieve the above purpose, the technical scheme of the invention is as follows: a composition capable of sterilizing and inhibiting viruses comprises the following components in percentage by mass: 0.4-0.6% of patchouli essential oil, 0.2-0.3% of lemon essential oil, 0.1-0.2% of geranium essential oil, 0.5-1% of cinnamon essential oil, 0.5-1% of eucalyptus essential oil, 0.2-0.3% of clove essential oil, 0.3-0.5% of peppermint essential oil, 45-55% of water, 8-12% of glycerin, 30-35% of propylene glycol and 3-7% of nano copper powder.
The patchouli essential oil has the effects of treating depression, calming, inducing estrus, nourishing, astringing, promoting urination, diminishing inflammation and resisting bacteria, and has the greatest characteristics of polymerization, and the wound can promote wound scarring, prevent inflammation and promote cell metabolism. The lemon essential oil can improve circulatory system functions, including promoting blood circulation to reduce blood pressure and stop nose blood; can strengthen immune system, purify body, improve digestive system function, decompose cellulite, and treat dyspepsia and constipation; has the functions of soothing and relieving headache and migraine, and is helpful for treating arthritis and rheumatism by combining acidic substances in the body. It also helps to clean acne, clean greasy skin and hair, and remove dead skin cells. The geranium essential oil contains citronellol, citronellyl formate, terpinene, geranic acid, geraniol, terpineol, citral, menthone and various trace mineral elements, and has the main functions of skin conditioning, and the active ingredients in the geranium extract have strong affinity with natural organic fat; the geranium essential oil has analgesic, astringent, antibacterial, scar extending, and cell defense enhancing effects. The cinnamon essential oil mainly contains components such as cinnamaldehyde and the like, and has various pharmacological activities such as antioxidation, anti-inflammatory, blood sugar reduction, cardiovascular disease resistance, anticancer and the like. Eucalyptus oil has good antibacterial and bactericidal properties and is therefore often used as a raw material for soaps, deodorants, perfumes and other personal hygiene products. Eucalyptus essential oil is diffused in the air, which helps to prevent the spread of bacteria and disinfect the air; can effectively relieve nasal sinus infection, influenza, bronchitis, cold nasal obstruction and other respiratory diseases; it also helps to relieve mental fatigue, muscle pain and debilitation. The oleum Caryophylli has antiinflammatory, antibacterial, and toothache relieving effects. The peppermint essential oil has double effects, can cool when hot and warm the body when cold, can treat cold, and has certain curative effects on dry cough, asthma, bronchitis, pneumonia and phthisis; has effects in relieving flatulence, relieving stomach ache, and heartburn; in addition, it can relieve pain, and is effective for migraine, and can also help to reduce fever.
Preferably, the nano copper powder has a size of-325 mesh and/or a purity of 99.7%.
The nano copper powder has greatly improved surface copper atom activity due to the surface effect caused by small particle size, namely the electron releasing capacity is improved by many times, so that a large amount of copper ions are released, and the released copper ions are positively charged and firmly adsorbed on a cell membrane by virtue of coulomb force when contacting with negatively charged microorganisms; at the same time, copper ions penetrate through cell membranes and enter the bacterial body to form sulfhydryl (-SH) and amino (-NH) groups on proteins in the bacterial body 2 ) And the like, so that the protein of the bacteria is coagulated, the cell membrane synthetase activity of the bacteria is destroyed, the structural change of the bacteria is damaged, the bacteria can continue to react with enzymes, DNA and the like to generate dysfunction, the bacteria die, copper ions can be dissolved out of the bacteria after the bacteria die, and the repeated sterilization effect can be realized. The sterilization principle of the superfine copper powder can not generate drug resistance to bacteria, is superior to antibiotics, and even if a trace amount of copper ions enter human bodies, the copper ions are harmless to the human bodies, can be naturally metabolized by the human bodies and can not be accumulated in the human bodies.
Preferably, the composition comprises the following components in mass ratio: 0.5% of patchouli essential oil, 0.25% of lemon essential oil, 0.1% of geranium essential oil, 0.75% of cinnamon essential oil, 0.75% of eucalyptus essential oil, 0.25% of clove essential oil, 0.4% of peppermint essential oil, 50% of water, 10% of glycerin, 32% of propylene glycol and 5% of nano copper powder.
Preferably, the composition is prepared by a process comprising the steps of:
s1, uniformly mixing patchouli essential oil, lemon essential oil, geranium essential oil, cinnamon essential oil, eucalyptus essential oil, clove essential oil and peppermint essential oil according to a proportion;
s2, uniformly mixing water, glycerol and propylene glycol according to a proportion;
and S3, uniformly mixing and stirring the components obtained in the steps S1 and S2, and then adding the nanometer copper powder and stirring to obtain the composition. In S3, the stirring speed was 800r/min. The composition is prepared in a sterile environment at normal temperature.
Use of a composition for the sterilization and inhibition of viruses, said composition comprising a carrier for use in daily textiles, garments. Garments include hospital doctor and nurse gowns, patient gowns and caretaker clothing, and antibacterial socks and underpants, antibacterial undergarments, clothing, hats, masks, shoes, insoles, gloves. Daily textiles include bed sheets, quilt covers, pillow towels, bath towels and rags.
Preferably, the composition is applied by spraying onto the surface of the carrier and/or by adding it during the carrier preparation process. The composition can be attached to the surface of a carrier in a superfine spray mode or added into a preparation process of carrier fibers, so that the fibers contain an effective amount of the composition, and the composition can be prepared into textiles with the functions of sterilizing and inhibiting viruses and can be repeatedly used, for example, clothes can be repeatedly washed, and the textiles can still sterilize and inhibit viruses after being washed.
Preferably, the composition is sprayed onto the mask surface. Most of masks used in daily life are disposable masks, especially for preventing virus transmission, at present, commonly used disposable masks are used for preventing virus transmission in a filtering mode, the service time of the masks is limited, the masks are required to be replaced for many times every day, and the masks are wasted, if the masks are forgotten to be replaced, the virus transmission cannot be well prevented, so that the masks capable of sterilizing and inhibiting viruses for a long time can solve the problems.
Preferably, the mask comprises three layers, wherein the inner layer is an SSS non-woven fabric skin-friendly layer, the middle layer is an FTFE micro-porous nano membrane filter layer, and the outermost layer is a non-woven fabric layer sprayed with the composition. A combination of multiple filtration layers is used to prevent the transfer of microorganisms, body fluids and particulates, and a bactericidal, antiviral composition is added that kills specific pathogens under specific contact conditions. The composition contains various active ingredients, and alcohols, benzene, phenols and other ingredients contained in essential oil act on viral envelope, so that virus inactivation can be realized, virus cell diffusion can be inhibited, and bacterial virus integrity can be destroyed. When the virus contacts the surface of the mask containing copper, copper ions are released, destroying the viral envelope, causing it to rupture, and the virus is destroyed.
Preferably, the spraying amount of the composition on the mask is 66g/m 2 . The composition can be sprayed on mask to instantly kill more than 99% of bacteria and viruses, and the nanometer copper powder can kill the rest bacteria and viruses for a long time, and can inactivate 99.97% of SARS-COV2 and 99% of human coronavirus (229E) after 1 min.
Compared with the prior art, the invention has the beneficial effects that:
1. the invention adopts a double sterilization mode of natural plant extraction medicament and nano copper powder, more than 99% of bacteria and viruses can be killed instantaneously, the nano copper powder can kill the residual bacteria and viruses for a long time, the total protective effect is 100%, and the superfine copper powder copper ions can be naturally metabolized by human body and cannot be accumulated in the human body.
2. The invention adopts various essential oils with health care effect, and the components such as alcohols, benzene, phenols and the like contained in the essential oils act on the viral envelope, so that the viruses can be inactivated, the intercellular diffusion of the viruses can be inhibited, and the integrity of the bacterial viruses can be damaged.
Detailed Description
In order that those skilled in the art will better understand the present invention, a further detailed description of embodiments of the present invention will be provided below, with the understanding that the present invention is described in some, but not all, embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the present invention without making any inventive effort, shall fall within the scope of the present invention.
It should be noted that, without conflict, the embodiments of the present invention and features of the embodiments may be combined with each other. The present invention will be described in detail with reference to examples.
Example 1
A composition capable of sterilizing and inhibiting viruses is prepared by the following method: uniformly mixing 0.5g of patchouli essential oil, 0.25g of lemon essential oil, 0.1g of geranium essential oil, 0.75g of cinnamon essential oil, 0.75g of eucalyptus essential oil, 0.25g of clove essential oil and 0.4g of peppermint essential oil to obtain phase A; then mixing 53g of water, 10g of glycerol and 32g of propylene glycol uniformly to obtain a phase B; mixing phase A and phase B, stirring, adding 5g nanometer copper powder, and mixing to obtain the final product.
Example 2
A composition capable of sterilizing and inhibiting viruses is prepared by the following method: uniformly mixing 0.4g of patchouli essential oil, 0.3g of lemon essential oil, 0.2g of geranium essential oil, 0.5g of cinnamon essential oil, 0.1g of eucalyptus essential oil, 0.2g of clove essential oil and 0.3g of peppermint essential oil to obtain phase A; then mixing 45g of water, 12g of glycerol and 30g of propylene glycol uniformly to obtain a phase B; mixing phase A and phase B, stirring, adding 4g nanometer copper powder, and mixing to obtain the final product.
Example 3
A composition capable of sterilizing and inhibiting viruses is prepared by the following method: uniformly mixing 0.6g of patchouli essential oil, 0.2g of lemon essential oil, 0.2g of geranium essential oil, 0.1g of cinnamon essential oil, 1g of eucalyptus essential oil, 0.3g of clove essential oil and 0.5g of peppermint essential oil to obtain phase A; then mixing water 55g, glycerin 8g and propylene glycol 35g uniformly to obtain phase B; mixing phase A and phase B, stirring, adding 7g nanometer copper powder, and mixing to obtain the final product.
Example 4
A composition having bactericidal and viral inhibiting functions for textile preparation comprising the steps of: the composition and plastic particles are extruded and granulated by a screw to obtain antibacterial master batches containing a certain amount of superfine copper powder and essential oil, then the antibacterial master batches and common particles are mixed together and melted, and then the antibacterial fiber containing five-thousandth of nanometer copper powder is spun according to the process requirement of melt spinning, so that the antibacterial daily textile containing five-thousandth of copper is obtained.
Example 5
The composition with the functions of sterilizing and inhibiting viruses is sprayed on the mask for sterilizing the mask, the structure of the mask is divided into three layers, the outermost non-woven fabric viral inactivating coating layer of the mask is a microporous nano membrane filter layer of FTFE, and the inner layer is a skin-friendly layer of SSS non-woven fabric. Using 25-40g/m 2 Is a nonwoven fabric of (a) a nonwoven fabric. The unit spray amount on the mask was 66 grams per square meter.The single mask spray composition cured to 2g. The effective quality guarantee and sterilization time is 2 years.
Comparative example 1
A composition capable of sterilizing and inhibiting viruses is prepared by the following method: uniformly mixing 0.5g of patchouli essential oil, 0.25g of lemon essential oil, 0.1g of geranium essential oil, 0.75g of cinnamon essential oil, 0.75g of eucalyptus essential oil, 0.25g of clove essential oil and 0.4g of peppermint essential oil to obtain phase A; then mixing 53g of water, 10g of glycerol and 32g of propylene glycol uniformly to obtain a phase B; mixing phase A and phase B, and stirring to obtain the above composition.
Test 1 inactivated Virus test
The composition was applied to mask materials for sterilization and virus killing tests.
Detection standard: ISO 18184:2019. The test results are shown in Table 1.
TABLE 1 norovirus detection
As shown in Table 1, the antiviral activity of the virus after 1min incubation of the composition was 98.73%, and the antiviral activity of the virus after 60min incubation was 99.49%.
Test 2 anti-SARS-CoV-2 Virus test
1. Test and consumable:
reagent: DMEM (Thermo Fisher) FBS (Gibco), methylcellulose (Millipore).
2. Test design
Amplification and titer determination of SARS-COV-2 Virus (WIV, genBank: MN 996528.1) P6 Generation SARS-CoV-2 Virus Vero-E6 cells were inoculated at 37C, 5% CO 2 Culturing in incubator for 48 hr, collecting cultured virus supernatant, centrifuging, packaging, and freezing at-80deg.C. Virus titers were determined in Vero-E6 cells using classical plaque assay and the virus diluted to 10 7 PFU/ml。
Sample preparation: cutting the corresponding samples into blocks of 40mm, performing disinfection treatment, and placing each sample into a 6cm dish; the sample is made of nano material textile.
Virus exposure: adding 200ul of virus stock solution into a dish, and naturally and completely dispersing the solution;
treatment and time: incubating the viruses and the materials for 120min, and simultaneously setting an equal amount of virus solution which is not subjected to cloth treatment as a control;
virus elution: after the corresponding treatment time, the sample square is clamped by a gun head and placed into a 50m Ep tube with a cap, 20ml of culture medium is added, the cap is covered, vortex shaking is carried out for 5 times, each time for 5 seconds, and viruses in the sample are eluted:
virus dilution: taking 2ml of virus supernatant as undiluted group (the rest samples are packaged and frozen), adding 200ul undiluted stock solution into 1.8ml of culture medium to obtain 10 -1 Diluting group, further repeating the above operation to obtain 10 -2 ，10 -3 ，10 -4 ，10 -5 Dilution;
plaque assay: cell confluency was observed and the assay was performed only at high confluency. The cell culture medium is replaced by 2% of maintenance medium, diluted virus is added into the maintenance medium, the virus is infected for 2 hours at 37 ℃, the maintenance medium is washed once by the maintenance medium of 2%, 3ml of semisolid culture medium (six-hole plate) can be added, and the culture medium is placed at 37 ℃ for 4d, so that plaque formation can be observed.
The test results are shown in Table 2.
TABLE 2 results of anti-SARS-CoV-2 Virus assay
| Processing time | Plaque number (PFU) | Bacteriostasis rate (%) |
| 1min | 3.2*10 3 | 99.97 |
| Control group | 9.7*10 6 | —— |
As can be seen from Table 2, the novel material treated by the composition provided by the scheme has the activity of resisting SARS-CoV-2 virus, and the inhibition rate of the SARS-CoV-2 virus by incubating the novel material and the virus for 2 hours is up to 99.97%.
Test 3 inactivated New coronavirus test
Experiments with copper powder alone for sterilization show that 4 cm of sterilized nonwoven fabric is placed in a laboratory dish for experiments, and after 10 minutes, the novel coronavirus 10000 is inactivated.
The natural plant extraction medicament is simply used and is not sprayed and transferred to the non-woven fabric of the mask, so that 99.8% of viruses can be inactivated within 1 minute, however, the medicament is transferred to the non-woven fabric and is sprayed and dried, the effect of 5% can be lost, and the virus inactivation rate can only reach 95%.
Therefore, the natural plant extraction medicament and the nanometer copper powder are combined, a sterilizing non-woven fabric with the length of 4 cm is placed in a test dish for experiment, the novel coronavirus 5000000 is inactivated within 1 minute, the efficacy is far superior to that of the pure copper powder, and the loss caused by the high temperature of the natural plant extraction medicament in the production and transfer process is compensated.
The above specific embodiments are provided for illustrative purposes only and are not intended to limit the invention, and modifications, no inventive contribution, will be made to the embodiments by those skilled in the art after having read the present specification, as long as they are within the scope of the patent statutes.
Claims (10)
1. A composition capable of sterilizing and inhibiting viruses, which is characterized by comprising the following components in mass ratio: 0.4-0.6% of patchouli essential oil, 0.2-0.3% of lemon essential oil, 0.1-0.2% of geranium essential oil, 0.5-1% of cinnamon essential oil, 0.5-1% of eucalyptus essential oil, 0.2-0.3% of clove essential oil, 0.3-0.5% of peppermint essential oil, 45-55% of water, 8-12% of glycerin, 30-35% of propylene glycol and 3-7% of nano copper powder.
2. A bactericidal and virucidal composition as in claim 1, wherein the composition includes the following components in mass ratio: 0.5% of patchouli essential oil, 0.25% of lemon essential oil, 0.1% of geranium essential oil, 0.75% of cinnamon essential oil, 0.75% of eucalyptus essential oil, 0.25% of clove essential oil, 0.4% of peppermint essential oil, 50% of water, 10% of glycerin, 32% of propylene glycol and 5% of nano copper powder.
3. A bactericidal and virally-inhibiting composition according to claim 2, wherein the nano-copper powder is-325 mesh in size and/or the nano-copper powder is 99.7% pure.
4. A bactericidal and virucidal composition as in claim 2, wherein the composition is prepared by a process comprising the steps of:
s1, uniformly mixing patchouli essential oil, lemon essential oil, geranium essential oil, cinnamon essential oil, eucalyptus essential oil, clove essential oil and peppermint essential oil according to a proportion;
s2, uniformly mixing water, glycerol and propylene glycol according to a proportion;
and S3, uniformly mixing and stirring the mixed solution obtained in the step S1 and the step S2, and then adding the nanometer copper powder and stirring to obtain the composition.
5. A composition for sterilizing and inhibiting viruses as claimed in claim 4 wherein in S3, the stirring speed is 800r/min.
6. Use of a composition according to any one of claims 1 to 5, wherein: the carrier for applying the composition comprises underwear, clothes, hat, mask, insole, glove, bed sheet, quilt cover, pillow towel, bath towel, and rag.
7. Use of a composition according to claim 6, wherein the composition is sprayable onto the surface of a carrier and/or is added during the carrier preparation process.
8. The use of the composition of claim 6, wherein the composition is sprayed onto the surface of a mask.
9. The use of the composition of claim 8, wherein the mask comprises three layers, an inner layer is an SSS nonwoven layer, an intermediate layer is a FTFE microporous nanomembrane filtration layer, and an outermost layer is a nonwoven layer of spray composition.
10. The use of the composition according to claim 9, wherein the composition is sprayed onto the outermost layer of the mask in an amount of 66g/m 2 。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310050130.5A CN116058388A (en) | 2023-02-01 | 2023-02-01 | Composition capable of sterilizing and inhibiting viruses and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310050130.5A CN116058388A (en) | 2023-02-01 | 2023-02-01 | Composition capable of sterilizing and inhibiting viruses and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116058388A true CN116058388A (en) | 2023-05-05 |
Family
ID=86169424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310050130.5A Pending CN116058388A (en) | 2023-02-01 | 2023-02-01 | Composition capable of sterilizing and inhibiting viruses and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116058388A (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008153077A1 (en) * | 2007-06-12 | 2008-12-18 | Hiroshima University | Anti-norovirus agent, and composition comprising the same |
| CN111407859A (en) * | 2020-04-29 | 2020-07-14 | 北京天然风尚健康科技有限公司 | Preparation method and application of armor essential oil composition with antibacterial and antiviral effects |
| CN112616861A (en) * | 2020-12-14 | 2021-04-09 | 杭州象外环保科技有限公司 | Novel natural plant extract essential oil coronavirus disinfectant and application thereof |
| KR102305665B1 (en) * | 2020-08-10 | 2021-09-28 | (주)네이처페어리 | Antiviral or antibacterial compositions comprising Dendropanax morbiferus |
| CN113767938A (en) * | 2021-08-30 | 2021-12-10 | 柳州市中医医院(柳州市壮医医院) | Zhuang nationality medicine air disinfectant |
| CN114246925A (en) * | 2020-09-22 | 2022-03-29 | 香港科技大学 | Traditional Chinese medicine essential oil and application thereof |
| CN114916564A (en) * | 2022-05-27 | 2022-08-19 | 成都中医药大学附属医院 | Essential oil composition for inhibiting novel coronavirus |
| CN114931250A (en) * | 2022-04-08 | 2022-08-23 | 浙江格林沃德非织造布有限公司 | Antiviral mask structure containing nano-copper and preparation process thereof |
| CN115363058A (en) * | 2021-07-18 | 2022-11-22 | 杭州绿键生物科技有限公司 | Novel disinfectant for effectively inactivating novel coronavirus |
-
2023
- 2023-02-01 CN CN202310050130.5A patent/CN116058388A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008153077A1 (en) * | 2007-06-12 | 2008-12-18 | Hiroshima University | Anti-norovirus agent, and composition comprising the same |
| CN111407859A (en) * | 2020-04-29 | 2020-07-14 | 北京天然风尚健康科技有限公司 | Preparation method and application of armor essential oil composition with antibacterial and antiviral effects |
| KR102305665B1 (en) * | 2020-08-10 | 2021-09-28 | (주)네이처페어리 | Antiviral or antibacterial compositions comprising Dendropanax morbiferus |
| CN114246925A (en) * | 2020-09-22 | 2022-03-29 | 香港科技大学 | Traditional Chinese medicine essential oil and application thereof |
| CN112616861A (en) * | 2020-12-14 | 2021-04-09 | 杭州象外环保科技有限公司 | Novel natural plant extract essential oil coronavirus disinfectant and application thereof |
| CN115363058A (en) * | 2021-07-18 | 2022-11-22 | 杭州绿键生物科技有限公司 | Novel disinfectant for effectively inactivating novel coronavirus |
| CN113767938A (en) * | 2021-08-30 | 2021-12-10 | 柳州市中医医院(柳州市壮医医院) | Zhuang nationality medicine air disinfectant |
| CN114931250A (en) * | 2022-04-08 | 2022-08-23 | 浙江格林沃德非织造布有限公司 | Antiviral mask structure containing nano-copper and preparation process thereof |
| CN114916564A (en) * | 2022-05-27 | 2022-08-19 | 成都中医药大学附属医院 | Essential oil composition for inhibiting novel coronavirus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102162992B1 (en) | Antibacterial dust mask | |
| CN105362351A (en) | Medicine composition for treating cutaneous pruritus disease and application thereof | |
| KR102173772B1 (en) | Antibacterial dust mask and method for manufacturing thereof | |
| CN108371191A (en) | A kind of air antiseptic and its preparation method and application | |
| CN106359472A (en) | Bactericidal compound essential oil and preparation method of same | |
| CN111297961A (en) | Dong medicine for promoting wound healing | |
| CN105148059A (en) | Plant oil external liniment capable of repelling mosquitos and preparation method thereof | |
| CN105708254B (en) | Both effectiveness magnetic therapy sleeping bag | |
| CN112121100B (en) | Itching-relieving and odor-removing chip, puerpera pad and preparation method of puerpera pad | |
| CN106266189A (en) | Compound recipe Radix Arnebiae (Radix Lithospermi) mosquito-expelling and antipruritic cream and preparation method thereof | |
| JP2009269904A (en) | Herbal medicinal composition for curing external wound and bedsore and method of manufacturing medicine from the composition | |
| CN116058388A (en) | Composition capable of sterilizing and inhibiting viruses and application thereof | |
| CN111481567B (en) | Compound ozone oil and preparation method and application thereof | |
| CN108721478A (en) | A kind of plant multi-effect compound agent of mosquito-proof sting | |
| KR100937688B1 (en) | Manufacturing method of functional topsheet made from vegetable fibers | |
| CN114515324A (en) | Traditional Chinese medicine epidemic prevention aromatherapy composition and product thereof | |
| CN104957952B (en) | There is the rhamnus crenata sieb.et zucc. carpet of health care function of driving mosquitoes | |
| CN106675838A (en) | Special laundry detergent with functions of removing bacteria and formaldehyde for infants | |
| CN103147271A (en) | Nano antibiosis and bacteriostasis cotton textile material and products thereof | |
| WO2021258654A1 (en) | Silver ion antibacterial hand sanitizer, preparation method therefor, and application thereof | |
| CN111035684A (en) | Ozone oil compound rhinitis gel and preparation method thereof | |
| CN111528233A (en) | Sterilization disinfectant and preparation method thereof | |
| CN101757119B (en) | Medicine composition for treating vaginitis as well as gel and preparation method thereof | |
| CN104695034A (en) | Traditional Chinese medicine mosquito expelling composition and application thereof | |
| CN110934809A (en) | Antibacterial and anti-inflammatory child skin-care talcum powder and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |